Virginia Beach dentist Dr. Cappy Sinclair whose practice is located at 1369 Laskin Rd Ste 3A is now administering two molecular tests that provide supplemental information about a patient’s periodontal disease. This information can be used to develop patient-specific treatment plans for periodontal disease therapy and to help establish the therapy endpoint.
The two salivary diagnostic tests, named MyPerioPath® and MyPerioID® PST®,are offered by OralDNA® Labs Inc., a subsidiary of Quest Diagnostics.
Specifically, the MyPerioPath test provides semi-quantitative levels of 11 different species of bacteria known to trigger periodontal disease. In addition to identifying the bacterial pathogens, the test provides a bacterial-related risk of disease progression and suggestions for suitable antibiotic therapy. The MyPerioID PST test detects genetic changes (DNA polymorphisms) that have been associated with increased incidence and/or progression of chronic periodontal disease in some studies.
According to Dr. Sinclair “We are very pleased to be one of the first dental practices in the area to utilize the MyPerioPathand MyPerioID PSTsalivary diagnostic tests, enhancing our ability to provide the best possible care.”
Periodontal disease is a chronic inflammatory disease that affects the gum tissue and other structures supporting the teeth. If left untreated, it can lead to tooth loss. Besides helping with tooth retention, successful periodontal treatment can help patients with diabetes to better control their disease.1,2 About 50% of Americans have gingival bleeding, the more common but less severe form of periodontal disease.3 Prevalence of more severe disease is more difficult to ascertain.
Several research studies have associated gum disease with other chronic inflammatory diseases such as diabetes, cardiovascular disease, and rheumatoid arthritis.4,5
For more information regarding the MyPerioPath® and MyPerioID® PST® salivary diagnostic tests, or to schedule an appointment, call Dr. Sinclair at (757)453-7657.